JKHY Stock Recent News
JKHY LATEST HEADLINES
JKHY's third-quarter fiscal 2025 results benefit from strong Core, Payments & Complementary segment growth.
Jack Henry & Associates, Inc. (NASDAQ:JKHY ) Q3 2025 Results Conference Call May 7, 2025 8:45 AM ET Company Participants Vance Sherard - VP, Investor Relations Greg Adelson - President & Chief Executive Officer Mimi Carsley - Chief Financial Officer Conference Call Participants Dan Perlin - RBC Rayna Kumar - Oppenheimer Vasu Govil - KBW Jason Kupferberg - Bank of America Darrin Peller - Wolfe Research Kartik Mehta - Northcoast Research Andrew Schmidt - Citi Andrew Bauch - Wells Fargo James Faucette - Morgan Stanley John Davis - Raymond James Operator Good day and welcome to the Jack Henry & Associates, Inc. Third Quarter Fiscal Year 2025 Results Conference Call. [Operator Instructions] Please note that this conference is being recorded.
Although the revenue and EPS for Jack Henry (JKHY) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Jack Henry (JKHY) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.19 per share a year ago.
Jack Henry & Associates posted about a 28% rise in third-quarter profit on Tuesday, helped by strong demand for the financial technology company's products and services.
Third quarter summary : GAAP revenue increased 8.6% and GAAP operating income increased 23.8% for the fiscal three months ended March 31, 2025, compared to the prior fiscal year quarter. Non-GAAP adjusted revenue increased 7.0% and non-GAAP adjusted operating income increased 17.6% for the fiscal three months ended March 31, 2025, compared to the prior fiscal year quarter.1 GAAP EPS was $1.52 per diluted share for the fiscal three months ended March 31, 2025, compared to $1.19 per diluted share in the prior fiscal year quarter.
I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. Despite a market sell-off, my investable universe outperformed SPY and SCHD year-to-date, with a loss of -1.83% compared to -5.49% and -4.64%. This month, 17 stocks had valuation rating changes; 10 were upgrades, including Jack Henry & Associates, West Pharma, and EOG Resources, all with strong expected returns.
Jack Henry and Associates' third-quarter fiscal 2025 results are likely to benefit from higher sales across all its segments.
Beyond analysts' top -and-bottom-line estimates for Jack Henry (JKHY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Operational efficiency, growth, and fraud take center stage amid economic uncertainty MONETT, Mo. , May 1, 2025 /PRNewswire/ -- Banks and credit unions are prioritizing operational efficiency while focusing on growing deposits and loans, according to Jack Henry's seventh annual Strategy Benchmark.